IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2476 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy

Devi Padmini, Madhu K, Ganapathy B, Sarma GRK, John Lisha, Kulkarni Chanda

Year : 2012| Volume: 44| Issue : 1 | Page no: 51-56

   This article has been cited by
 
1 A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy
Sameer Khasbage, Ravindra Shukla, Praveen Sharma, Surjit Singh
Journal of Diabetes. 2021; 13(7): 532
[Pubmed]  [Google Scholar] [DOI]
2 Comparison of efficacy and safety of gabapentin and duloxetine in painful diabetic peripheral neuropathy: A systematic review and meta-analysis of randomised controlled trials
Yuan-Chun Ko, Che-Hsiung Lee, Chung-Sheng Wu, Yu-Jui Huang
International Journal of Clinical Practice. 2021; 75(11)
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and Safety of TENS and Duloxetine in Patients with Painful Diabetic Neuropathy: A Single Blind Randomized Clinical Trial
Bahram Naderi Nabi, Alia Saberi, Babak Bakhshayesh Eghbali, Mozaffar Hosseininezhad, Gelareh Biazar, Amir Abbasi Malekabadi, Ladan Mirmansouri
Journal of Advances in Medical and Biomedical Research. 2021; 29(136): 286
[Pubmed]  [Google Scholar] [DOI]
4 Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial
Ebrahim Salehifar, Ghasem Janbabaei, Narjes Hendouei, Abbas Alipour, Nasim Tabrizi, Razieh Avan
Clinical Drug Investigation. 2020; 40(3): 249
[Pubmed]  [Google Scholar] [DOI]
5 Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study
Mamoonah Chaudhry, Marco Alessandrini, Jacobus Rademan, Tyren M Dodgen, Francois E Steffens, Danie G van Zyl, Andrea Gaedigk, Michael S Pepper
Pharmacogenomics. 2017; 18(5): 433
[Pubmed]  [Google Scholar] [DOI]
6 Amisulpride as Add-on Treatment for Resistant Obsessive-Compulsive Disorder
Chanoch Miodownik,Joseph Bergman,Paul P. Lerner,Anatoly Kreinin,Vladimir Lerner
Clinical Neuropharmacology. 2015; 38(1): 26
[Pubmed]  [Google Scholar] [DOI]
7 Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events
Mark S. Juhn,Bruce Parsons,Roxanna Varvara,Alesia Sadosky
Current Medical Research & Opinion. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
8 Systematic Review and Meta-Analysis of Pharmacological Therapies for Painful Diabetic Peripheral Neuropathy
Sonya J. Snedecor,Lavanya Sudharshan,Joseph C. Cappelleri,Alesia Sadosky,Sonam Mehta,Marc Botteman
Pain Practice. 2014; 14(2): 167-184
[Pubmed]  [Google Scholar] [DOI]
9 From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy
Dan Ziegler,Vivian Fonseca
Journal of Diabetes and its Complications. 2014;
[Pubmed]  [Google Scholar] [DOI]
10 Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Verma, V., Singh, N., Singh Jaggi, A.
Current Neuropharmacology. 2014; 12(1): 44-56
[Pubmed]  [Google Scholar]
11 Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: A network meta-analysis
Rudroju, N., Bansal, D., Teja Talakokkula, S.,Bhansali, A., Ghai, B.
Pain Physician. 2013; 16(6): E705-E714
[Pubmed]  [Google Scholar]
12 Mechanisms and pharmacology of diabetic neuropathy experimental and clinical studies
Magdalena Zychowska,Ewelina Rojewska,Barbara Przewlocka,Joanna Mika
Pharmacological Reports. 2013; 65(6): 1601
[Pubmed]  [Google Scholar] [DOI]
13 Understanding the pharmacokinetics of anxiolytic drugs
Alfredo Carlo Altamura,Donatella Moliterno,Silvia Paletta,Michele Maffini,Massimo Carlo Mauri,Silvio Bareggi
Expert Opinion on Drug Metabolism & Toxicology. 2013; 9(4): 423
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow